Recurrent trichilemmal carcinoma of the periorbital region treated with IMRT radiotherapy: A case report and a review of literature

Author:

Gao Shan1,Xu Qin2,Lan Yanli1,He Lang2

Affiliation:

1. Cancer Prevention and Treatment Institute of Chengdu, Department of Otolaryngology-Head and Neck Surgery, Chengdu, China

2. Cancer Prevention and Treatment Institute of Chengdu, Department of Oncology, Chengdu Fifth People’s Hospital (The Second Clinical Medical College, Affiliated Fifth People’s Hospital of Chengdu University of Traditional Chinese Medicine), Chengdu, China.

Abstract

Rationale: Trichilemmal carcinoma (TLC) is a rare malignant cutaneous adnexal tumor usually accept surgery. This report describes an elderly patient with recurrence TLC of the periorbital region after surgery who was subsequently treated with IMRT radiotherapy. After 2-years follow-up visit, there was no progress or metastasis. Introduction: TLC is a rare malignant cutaneous adnexal tumor. It usually occurs on sun-exposed areas in elderly people but rarely occurs in the periorbital region. Most cases accept surgery or micrographic Mohs surgery. Recurrence or metastasis of this neoplasm was seldom reported in the medical literature after enough tumor-free margin surgery. And radiotherapy was seldom reported in the treatment for patients of TLC. Patient concerns: Here we report an elderly patient with recurrence TLC of the periorbital region after surgery who was subsequently treated with radiotherapy with a total dose of 66 Gy. Two years later, the patient was admitted head, neck, chest, abdomen CT scan, and no progress or metastasis was detected after 2-years follow-up. Diagnosis: Trichilemmal carcinoma of the periorbital region. Interventions: We describe the clinical characteristics, pathological features, and choice of examination methods of a patient with TLC in the periorbital region. And we use the radical radiotherapy to treat this case. Outcomes: There are no progress or metastasis after 2-years follow-up. Conclusion: Radiotherapy is a good option for patients with TLC if the patient refuses surgery or fails to achieve a satisfactory tumor-free margin or relapses after surgery.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine

Reference21 articles.

1. Trichilemmal carcinoma.;Billingsley;J Am Acad Dermatol,1997

2. Management of trichilemmal carcinoma: an update and comprehensive review of the literature.;Hamman;Dermatol Surg,2014

3. Malignant hair follicle tumors of the periorbital region: a review of literature and suggestion of a management guideline.;Sia;Orbit,2016

4. Survival study and clinicopathological evaluation of trichilemmal carcinoma.;Zhuang;Mol Clin Oncol,2013

5. Mohs micrographic surgery in the treatment of trichilemmal carcinoma: the Mayo Clinic experience.;Tolkachjov;J Am Acad Dermatol,2015

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3